-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ORcEJ9nbi+xcbWkSg+QhPir6i10rEjxmvumE7ux3E09DnXExvzZrfH/DIqPQRQoZ C/yGVhn/wu5KWE0fr6HZ6Q== 0001157523-07-005868.txt : 20070605 0001157523-07-005868.hdr.sgml : 20070605 20070605120542 ACCESSION NUMBER: 0001157523-07-005868 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070605 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070605 DATE AS OF CHANGE: 20070605 FILER: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21116 FILM NUMBER: 07900005 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 8-K 1 a5418930.txt USANA HEALTH SCIENCES, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------ FORM 8-K ------------ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 5, 2007 USANA HEALTH SCIENCES, INC. (Exact name of registrant as specified in its charter) Commission File No. 0-21116 Utah 87-0500306 (State or other jurisdiction of (IRS Employer Identification incorporation) Number) 3838 West Parkway Boulevard Salt Lake City, Utah 84120 (Address of principal executive offices, Zip Code) Registrant's telephone number, including area code: (801) 954-7100 Former name or former address, if changed since last report: Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 8.01 Other Events On June 5, 2007, USANA Health Sciences, Inc. issued a press release announcing that it has signed a letter of intent to sell certain assets and inventory associated with the third-party contract manufacturing business at its Draper, Utah, facility, the terms of which were not disclosed. The release also announced that the sale of this business is anticipated to be effective sometime during the third quarter of 2007. A copy of the press release is furnished herewith as Exhibit 99 to this Current Report on Form 8-K and is incorporated herein by reference. The Company will also post this document on its corporate website, www.usanahealthsciences.com, under the "investors" link. Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit 99 Press release issued by USANA Health Sciences, Inc. dated June 5, 2007 (furnished herewith). SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. USANA HEALTH SCIENCES, INC. By: /s/ Gilbert A. Fuller Gilbert A. Fuller, Chief Financial Officer Date: June 5, 2007 EX-99 2 a5418930ex_99.txt EXHIBIT 99 Exhibit 99 USANA Health Sciences Signs Letter of Intent to Sell Its U.S. Third-Party Contract Manufacturing Business SALT LAKE CITY--(BUSINESS WIRE)--June 5, 2007--USANA Health Sciences, Inc. (NASDAQ:USNA) announced today that, consistent with its long-term objectives, the Company has signed a letter of intent to sell certain assets and inventory associated with the third-party contract manufacturing business at its Draper, Utah, facility. The terms of this transaction were not disclosed, however it is anticipated that the sale of this business will be effective sometime during the third quarter of 2007. Revenues from this business segment totaled $1.95 million in the first quarter of 2007. The Company will retain the assets associated with manufacturing and packaging its Sense skin and beauty care products and will continue to manufacture these products at its current facility in Draper, Utah. David A. Wentz, USANA's President said, "The long-term focus of USANA continues to be manufacturing and distributing our high-quality health and beauty products. The sale of our third-party contract manufacturing business will allow us to focus 100% of our efforts on growing and expanding our direct selling business." About USANA USANA develops and manufactures high-quality nutritional, personal-care, and weight management products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Malaysia, Mexico, the Netherlands and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com. CONTACT: USANA Riley Timmer, Investor Relations, 801-954-7922 investor.relations@us.usana.com -----END PRIVACY-ENHANCED MESSAGE-----